00:46:10 EDT Mon 23 Oct 2017
Enter Symbol
or Name
USA
CA



Z:VRX - VALEANT PHARMACEUTICALS INTERNAT - http://www.valeant.com00:46:10 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VRX - Z0.212.14 · 12.184.712.13-0.35-2.89,259.1109,17428,08312.40  12.46  12.0924.30  8.3119:59:56Oct 1615 min RT 2¢

Recent Trades - Last 10 of 28083
Time ETExPriceChangeVolume
19:59:56Z12.18-0.301,300
19:57:44Z12.15-0.33200
19:55:26Z12.15-0.33555
19:51:24Z12.16-0.3245
19:46:46Z12.16-0.32125
19:45:16Z12.15-0.33100
19:44:28Z12.17-0.311,000
18:32:28Z12.15-0.33750
18:30:32Z12.19-0.29100
18:29:58Z12.19-0.293,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2017-10-16 20:34U:VRXNews ReleaseValeant And One Of Its Subsidiaries Announce Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes
2017-10-12 08:00U:VRXNews ReleaseOrtho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ™ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile
2017-10-12 08:00U:VRXNews ReleaseOrtho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ ™ (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile
2017-10-05 19:46U:VRXNews ReleaseVRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors
2017-10-04 17:16U:VRXNews ReleaseSolta Medical Receives FDA 510(k) Clearance for Thermage FLX ™ System, Newest Generation Skin Smoothing Technology
2017-10-04 08:00U:VRXNews ReleaseSolta Medical Receives FDA 510(k) Clearance for Thermage FLX™ System, Newest Generation Skin Smoothing Technology
2017-10-03 08:00U:VRXNews ReleaseBausch + Lomb Introduces Biotrue ® ONEday for Astigmatism Contact Lenses in Europe
2017-10-03 07:00U:VRXNews ReleaseValeant Will Release Third-Quarter 2017 Financial Results On November 7
2017-10-02 19:47U:VRXNews ReleaseValeant Announces Pricing Of Private Offering Of Senior Secured Notes
2017-10-02 07:36U:VRXNews ReleaseValeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount